Forte Biosciences, Inc. (FBRX) Explores New Drug CandidatesForte Biosciences Inc.BATS:FBRXtraderspro_chartsForte Biosciences, Inc. (FBRX) develops therapies for autoimmune and inflammatory diseases, aiming to better control immune responses with targeted treatments. The company grows by advancing its clinical pipeline, exploring new drug candidates, and meeting rising demand for effective options in chronic immune conditions where current therapies fall short. On the chart, FBRX printed a confirmation bar with increasing volume as price moved above the .236 Fibonacci level and into the momentum zone. A trailing stop can be established using Fibonacci levels on the Fibonacci snap tool, helping manage risk while allowing momentum to continue.